Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1976 1
1977 1
1978 1
1980 3
1984 2
1988 1
1989 2
1990 1
1991 1
1994 1
1995 1
1996 6
1997 7
1998 8
1999 4
2000 2
2001 3
2002 2
2004 1
2005 1
2009 1
2012 1
2020 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Toward clinical trials of DNA vaccines against malaria.
Hoffman SL, Doolan DL, Sedegah M, Wang R, Scheller LF, Kumar A, Weiss WR, Le TP, Klinman DM, Hobart P, Norman JA, Hedstrom RC. Hoffman SL, et al. Among authors: hobart p. Immunol Cell Biol. 1997 Aug;75(4):376-81. doi: 10.1038/icb.1997.59. Immunol Cell Biol. 1997. PMID: 9315481 Review.
Plasmid vaccines and therapeutics: from design to applications.
Manthorpe M, Hobart P, Hermanson G, Ferrari M, Geall A, Goff B, Rolland A. Manthorpe M, et al. Among authors: hobart p. Adv Biochem Eng Biotechnol. 2005;99:41-92. doi: 10.1007/10_003. Adv Biochem Eng Biotechnol. 2005. PMID: 16568888 Review.
DNA vaccination as an approach to malaria control: current status and strategies.
Doolan DL, Hedstrom RC, Gardner MJ, Sedegah M, Wang H, Gramzinski RA, Margalith M, Hobart P, Hoffman SL. Doolan DL, et al. Among authors: hobart p. Curr Top Microbiol Immunol. 1998;226:37-56. doi: 10.1007/978-3-642-80475-5_3. Curr Top Microbiol Immunol. 1998. PMID: 9479834 Review. No abstract available.
Nucleic acid malaria vaccines. Current status and potential.
Hoffman SL, Doolan DL, Sedegah M, Gramzinski R, Wang H, Gowda K, Hobart P, Margalith M, Norman J, Hedstrom RC. Hoffman SL, et al. Among authors: hobart p. Ann N Y Acad Sci. 1995 Nov 27;772:88-94. doi: 10.1111/j.1749-6632.1995.tb44734.x. Ann N Y Acad Sci. 1995. PMID: 8546416 Review. No abstract available.
The development of a multivalent DNA vaccine for malaria.
Hedstrom RC, Doolan DL, Wang R, Gardner MJ, Kumar A, Sedegah M, Gramzinski RA, Sacci JB Jr, Charoenvit Y, Weiss WR, Margalith M, Norman JA, Hobart P, Hoffman SL. Hedstrom RC, et al. Among authors: hobart p. Springer Semin Immunopathol. 1997;19(2):147-59. doi: 10.1007/BF00870265. Springer Semin Immunopathol. 1997. PMID: 9406343 Review. No abstract available.
DNA vaccines for malaria: the past, the present, & the future.
Doolan DL, Hedstrom RC, Wang R, Sedegah M, Scheller LF, Hobart P, Norman JA, Hoffman SL. Doolan DL, et al. Among authors: hobart p. Indian J Med Res. 1997 Aug;106:109-19. Indian J Med Res. 1997. PMID: 9291681 Review.
Intravenous diclofenac and orphenadrine for the treatment of postoperative pain after remifentanil-based anesthesia : A double-blinded, randomized, placebo-controlled study.
Zeiner S, Haider T, Zotti O, Thüringer K, Höbart P, Kimberger O, Knolle E. Zeiner S, et al. Among authors: hobart p. Wien Klin Wochenschr. 2023 Feb;135(3-4):67-74. doi: 10.1007/s00508-022-02131-x. Epub 2022 Dec 28. Wien Klin Wochenschr. 2023. PMID: 36576555 Free PMC article. Clinical Trial.
54 results